Shares of Atara Biotherapeutics, Inc. (ATRA) are gaining about 42 percent in Thursday morning trading after the company announced a regulatory update following a recent Type A meeting with the U.S. FDA to discuss the Complete Response Letter issued for the Biologics License Application for Tabelecleucel.
The company's shares are currently trading at $7.31 on the Nasdaq, up 42.45 percent. The stock opened at $7.85 and has climbed as high as $7.89 so far in today's session. Over the past year, it has traded in a range of $3.92 to $19.15.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.